163 related articles for article (PubMed ID: 29533008)
21. Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes.
Stanelle EJ; Christison-Lagay ER; Healey JH; Singer S; Meyers PA; La Quaglia MP
Ann Surg Oncol; 2013 Jan; 20(1):73-9. PubMed ID: 22878620
[TBL] [Abstract][Full Text] [Related]
22. Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization.
Skytting BT; Szymanska J; Aalto Y; Lushnikova T; Blomqvist C; Elomaa I; Larsson O; Knuutila S
Cancer Genet Cytogenet; 1999 Nov; 115(1):39-46. PubMed ID: 10565298
[TBL] [Abstract][Full Text] [Related]
23. Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report.
Mercolini F; Merks JHM; Minard-Colin V; Cameron A; van Scheltinga SEJT; Sher O; Fichera G; Orbach D; Glosli H; Coppadoro B; Gallego S; Chisholm JC; Bisogno G
Pediatr Blood Cancer; 2023 Mar; 70(3):e30143. PubMed ID: 36519598
[TBL] [Abstract][Full Text] [Related]
24. Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group.
Scheer M; Dantonello T; Hallmen E; Vokuhl C; Leuschner I; Sparber-Sauer M; Kazanowska B; Niggli F; Ladenstein R; Bielack SS; Klingebiel T; Koscielniak E
Pediatr Blood Cancer; 2016 Jul; 63(7):1198-206. PubMed ID: 27003095
[TBL] [Abstract][Full Text] [Related]
25. Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005).
Brennan B; Zanetti I; Orbach D; Gallego S; Francotte N; Van Noesel M; Kelsey A; Casanova M; De Salvo GL; Bisogno G; Ferrari A
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286582
[TBL] [Abstract][Full Text] [Related]
26. The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents.
Scheer M; Vokuhl C; Bauer S; Fuchs J; Loff S; Timmermann B; Münter M; Henssen AG; Kazanowska B; Niggli F; Ladenstein R; Ljungman G; Koscielniak E; Klingebiel T;
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3735-3747. PubMed ID: 34272609
[TBL] [Abstract][Full Text] [Related]
27. Synovial sarcoma: Do children do better?
Smolle MA; Parry M; Jeys L; Abudu S; Grimer R
Eur J Surg Oncol; 2019 Feb; 45(2):254-260. PubMed ID: 30077520
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients.
Yaser S; Salah S; Al-Shatti M; Abu-Sheikha A; Shehadeh A; Sultan I; Salem A; Sughayer M; Al-Loh S; Al-Mousa A
Med Oncol; 2014 Jun; 31(6):958. PubMed ID: 24770952
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and treatment of patients with advanced synovial sarcoma: A single-center experience.
Ates O; Aksoy S; Yeter H; Sunar V; Kertmen N; Dizdar O; Turker A; Kars A
Indian J Cancer; 2017; 54(1):321-325. PubMed ID: 29199714
[TBL] [Abstract][Full Text] [Related]
30. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
[TBL] [Abstract][Full Text] [Related]
31. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189
[TBL] [Abstract][Full Text] [Related]
32. Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group.
Orbach D; Mc Dowell H; Rey A; Bouvet N; Kelsey A; Stevens MC
Pediatr Blood Cancer; 2011 Dec; 57(7):1130-6. PubMed ID: 21495161
[TBL] [Abstract][Full Text] [Related]
33. Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG).
Moreau-Bachelard C; Campion L; Toulmonde M; Le Cesne A; Brahmi M; Italiano A; Mir O; Piperno-Neumann S; Laurence V; Firmin N; Penel N; Duffaud F; Chevreau C; Bertucci F; Narciso B; Dubray-Longeras P; Delcambre C; Saada-Bouzid E; Boudou-Rouquette P; Soulie P; Perrin C; Blay JY; Bompas E
ESMO Open; 2022 Apr; 7(2):100402. PubMed ID: 35202953
[TBL] [Abstract][Full Text] [Related]
34. Enhancer of zeste homologue 2 (EZH2) expression in synovial sarcomas as a promising indicator of prognosis.
Yalçınkaya U; Uğraş N; Özgün G; Ocakoğlu G; Deligönül A; Çetintaş SK; Bilgen MS
Bosn J Basic Med Sci; 2017 Nov; 17(4):302-308. PubMed ID: 28738014
[TBL] [Abstract][Full Text] [Related]
35. Expression of MYCN in pediatric synovial sarcoma.
Somers GR; Zielenska M; Abdullah S; Sherman C; Chan S; Thorner PS
Mod Pathol; 2007 Jul; 20(7):734-41. PubMed ID: 17464317
[TBL] [Abstract][Full Text] [Related]
36. Synovial sarcoma relapses in children and adolescents: prognostic factors, treatment, and outcome.
Soole F; Maupain C; Defachelles AS; Taque S; Minard-Colin V; Bergeron C; De Rycke Y; Orbach D
Pediatr Blood Cancer; 2014 Aug; 61(8):1387-93. PubMed ID: 24664883
[TBL] [Abstract][Full Text] [Related]
37. Synovial sarcoma: the importance of size and location for survival.
Deshmukh R; Mankin HJ; Singer S
Clin Orthop Relat Res; 2004 Feb; (419):155-61. PubMed ID: 15021147
[TBL] [Abstract][Full Text] [Related]
38. Tumor mutation burden and checkpoint immunotherapy markers in primary and metastatic synovial sarcoma.
He M; Abro B; Kaushal M; Chen L; Chen T; Gondim M; Yan W; Neidich J; Dehner LP; Pfeifer JD
Hum Pathol; 2020 Jun; 100():15-23. PubMed ID: 32387103
[TBL] [Abstract][Full Text] [Related]
39. The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas.
Ferrari A; Brecht IB; Koscielniak E; Casanova M; Scagnellato A; Bisogno G; Alaggio R; Cecchetto G; Catania S; Meazza C; Int-Veen C; Kirsch S; Dantonello T; Carli M; Treuner J
Pediatr Blood Cancer; 2005 Aug; 45(2):128-34. PubMed ID: 15852434
[TBL] [Abstract][Full Text] [Related]
40. Histology and grading are important prognostic factors in synovial sarcoma.
Bianchi G; Sambri A; Righi A; Dei Tos AP; Picci P; Donati D
Eur J Surg Oncol; 2017 Sep; 43(9):1733-1739. PubMed ID: 28579008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
